Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone.

Name: Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone.
Author: Cheson, Bruce D

Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone. — المؤلف: Cheson, Bruce D — Annals of hematology 20170201

المؤلف: Cheson, Bruce D
النشر: Annals of hematology 20170201
الوصف: 253-259 p.
الموضوعات: Aged؛ Antibodies, Monoclonal, Humanized؛ Antineoplastic Combined Chemotherapy Protocols؛ Bendamustine Hydrochloride؛ Female؛ Humans؛ Lymphoma, Non-Hodgkin؛ Male